Exploring the Pharmacological Potential of Metformin for Neurodegenerative Diseases
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Aging Neuroscience"
DOI: 10.3389/fnagi.2022.838173
Abstract: Metformin, one of the first-line of hypoglycemic drugs, has cardioprotective, anti-inflammatory and anticancer activities, in addition to its proven hypoglycemic effects. Furthermore, the preventive and therapeutic potential of metformin for neurodegenerative diseases has become a… read more here.
Keywords: pharmacological potential; metformin neurodegenerative; neurodegenerative diseases; exploring pharmacological ... See more keywords